Showing results (111-120 of 138) with videos related to

Sort By:
Pageof 14
The Canadian Veterinary Journal = La Revue Veterinaire Canadienne|March 18, 2026
Triple-phase contrast-enhanced computed tomography findings for feline cranial mediastinal tumors: Pilot studyYoshimichi Goda, Kiwamu Hanazono, Ai Hori, et al.
Pathology International|December 1, 2011
A clinicopathological and immunohistological re-evaluation of adenosquamous carcinoma of the lungMasaki Shimoji, Takashi Nakajima, Chihiro Yamatani, et al.
Japanese Journal of Clinical Oncology|November 12, 2023
Rare but clinically important salivary gland-type tumor of the lung: A reviewShinkichi Takamori, Yasushi Yatabe, Atsushi Osoegawa, et al.
Japanese Journal of Clinical Oncology|August 19, 2024
The Lung Cancer Surgical Study Group of the Japan Clinical Oncology Group: outstanding contribution and entering a new phaseKazuo Nakagawa, Masaya Yotsukura, Takahiro Mimae, et al.
BMC Cancer|October 29, 2014
Prospective genetic profiling of squamous cell lung cancer and adenosquamous carcinoma in Japanese patients by multitarget assaysHirotsugu Kenmotsu, Masakuni Serizawa, Yasuhiro Koh, et al.
Scientific Reports|November 21, 2025
Novel CYP2A7/CYP2A6 germline hybrids associated with mutation burden in lung cancer revealed by whole-genome long-read sequencingSumiko Ohnami, Keiichi Hatakeyama, Takeshi Nagashima, et al.
Lung Cancer (Amsterdam, Netherlands)|March 25, 2014
Molecular profiling of small cell lung cancer in a Japanese cohortKazushige Wakuda, Hirotsugu Kenmotsu, Masakuni Serizawa, et al.
JCO Clinical Cancer Informatics|September 26, 2022
Artificial Intelligence-Powered Prediction of ALK Gene Rearrangement in Patients With Non-Small-Cell Lung CancerYukihiro Terada, Toshihiro Takahashi, Takamitsu Hayakawa, et al.
Clinical Lung Cancer|May 23, 2025
Impact of TP53 Co-Mutation on Clinicopathological Features, Prognosis, Recurrence Patterns, and the Efficacy of EGFR-TKI Treatment After Recurrence in Resected Early-Stage EGFR-Mutated Lung AdenocarcinomaTatsuya Masuda, Shinya Katsumata, Mitsuhiro Isaka, et al.
BMC Cancer|November 9, 2016
Frequency of EGFR T790M mutation and multimutational profiles of rebiopsy samples from non-small cell lung cancer developing acquired resistance to EGFR tyrosine kinase inhibitors in Japanese patientsRyo Ko, Hirotsugu Kenmotsu, Masakuni Serizawa, et al.
Pageof 14